DANIEL YANOV: Open Payments
NPI 1144987504 · CONCORD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,630 in 25 payments from 8 companies in 2025. Trend: 2023 $301 · 2024 $300 · 2025 $1,630
Food & beverage: $1,630
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $557 |
| UCB, Inc. | 4 | $374 |
| Incyte Corporation | 2 | $190 |
| Regeneron Healthcare Solutions, Inc. | 3 | $189 |
| Organon LLC | 1 | $150 |
| Janssen Biotech, Inc. | 1 | $111 |
| GENZYME CORPORATION | 1 | $35 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $24 |
Products named: Bimzelx, SKYRIZI, Opzelura, RINVOQ, VTAMA, LIBTAYO, TREMFYA, DUPIXENT.
Industry payments across CA — which companies pay providers there.
